According to DataM Intelligence, the global ambulatory blood pressure monitoring (ABPM) devices market size reached US$ 1.33 Billion in 2024 from US$ 1.21 Billion in 2023 and is expected to reach US$ ...
Medtronic (NYSE: MDT) today announced new long-term results from its final report of the SPYRAL HTN-ON MED trial.
4d
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new, long-term results from its final report of the SPYRAL HTN-ON MED randomized clinical trial, showing that ...
Medtronic announced that long-term results from its final report of the SPYRAL HTN-ON MED trial showed that patients treated wi ...
Resistant hypertension is a silent problem that can quietly damage your heart and brain. Dr Ezhumalai shares 6 tips to manage ...
The next time you get your blood pressure checked, expect your medical provider to be a bit more aggressive about high levels. And if you like a glass of wine with dinner or a cocktail on the weekends ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback